![](https://cdn.cancerletter.com/media/2020/04/11054249/Esther-Welkowsky_square.jpg)
![](https://cdn.cancerletter.com/media/2020/04/11054249/Esther-Welkowsky_square.jpg)
Esther Welkowsky was named vice president of Clinical Operations at Elicio Therapeutics, a next generation immuno-oncology company. Welkowsky has managed clinical operations teams for oncology clinical trials and was most recently executive director of Clinical Operations at Allogene.